Laura E. Johnson
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Immunology 25
- Immunotherapy and Immune Responses 24
-
- vaccines and immunoinformatics approaches 7
- RNA Interference and Gene Delivery 5
- Co-authors
- Douglas G. McNeel (29 shared papers)Hector F. DeLuca (2 shared papers)Thomas Frye (7 shared papers)Jens C. Eickhoff (11 shared papers)Brian M. Olson (6 shared papers)Glenn Liu (10 shared papers)Edward J. Dunphy (3 shared papers)David L. Paterson (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)Cancer Immunology Immunotherapy (4 papers)American Journal of Infection Control (3 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Laura E. Johnson
65 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 108
- Molecular Medicine 248
- Immunology 706
- Applied Microbiology and Biotechnology 63
- Oncology 421
- Endocrinology 74
Countries citing papers authored by Laura E. Johnson
This map shows the geographic impact of Laura E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Johnson more than expected).
Fields of papers citing papers by Laura E. Johnson
This network shows the impact of papers produced by Laura E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Johnson. The network helps show where Laura E. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 249 | |
| 2 | 2009 | 199 | |
| 3 | 2001 | 143 | |
| 4 | 2010 | 100 | |
| 5 | 2009 | 75 | |
| 6 | 2019 | 59 | |
| 7 | 2008 | 57 | |
| 8 | 2005 | 54 | |
| 9 | 2015 | 54 | |
| 10 | 2014 | 50 | |
| 11 | 2018 | 50 | |
| 12 | 2010 | 49 | |
| 13 | 2006 | 49 | |
| 14 | 2014 | 48 | |
| 15 | 2002 | 43 | |
| 16 | 2022 | 41 | |
| 17 | 2013 | 37 | |
| 18 | 2012 | 31 | |
| 19 | 2023 | 31 | |
| 20 | 2012 | 28 |
About Laura E. Johnson
Laura E. Johnson is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (24 papers), vaccines and immunoinformatics approaches (7 papers), Prostate Cancer Treatment and Research (6 papers), RNA Interference and Gene Delivery (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Cancer Research and Treatments (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Molecular Medicine (248 citations), Immunology (706 citations), Applied Microbiology and Biotechnology (63 citations), Oncology (421 citations) and Endocrinology (74 citations). Laura E. Johnson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Douglas G. McNeel, Hector F. DeLuca, Thomas Frye, Jens C. Eickhoff, Brian M. Olson, Glenn Liu, Edward J. Dunphy, David L. Paterson, Ameet Hingwe and Mary Jane Staab. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, American Journal of Infection Control and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.